Braftovi 75 MG capsule 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F9GH9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,852
Award facts
- Contract value 100% obligated
- $31,851.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,851.73 to AmerisourceBergen Drug Corp for the supply of BRAFTOVI 75 mg capsules (90-count units) under a firm fixed-price contract type. This non-set-aside award was issued on December 17, 2025, with an ultimate completion date of January 9, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for BRAFTOVI, an oncology medication, exemplifies the company's role in fulfilling specialized pharmaceutical procurement needs across multiple therapeutic domains. The competitively awarded contract reflects AmerisourceBergen's established capability to meet federal medical supply requirements and its significant position within the DLA's pharmaceutical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F9GH9?
SPE2DR26F9GH9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F9GH9 worth?
The government has obligated $31,852 on SPE2DR26F9GH9.
Is contract SPE2DR26F9GH9 an order under another contract?
Yes. SPE2DR26F9GH9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GH9 competed?
The extent of competition for SPE2DR26F9GH9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award